Bicara Therapeutics Inc.
BCAX
24 insider filings · Latest: May 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Feb 25 9:03 PM | Cohlhepp Ryan | Proposed Sale | 3,631 | $18.04 | $65.5K | — | View → |
| Jan 22, 2026 | Jan 26 9:34 PM | Ryan CohlheppDirector, President and COO | Sale | 3,828 | $18.10 | $69.3K | 210,164(D) | View → |
| Jan 22, 2026 | Jan 26 9:33 PM | Ivan HyepChief Financial Officer | Sale | 1,882 | $18.15 | $34.2K | 145,355(D) | View → |
| Jan 22, 2026 | Jan 22 9:07 PM | Cohlhepp Ryan | Proposed Sale | 3,828 | $16.97 | $65.0K | — | View → |
| Jan 22, 2026 | Jan 22 9:03 PM | Hyep Ivan | Proposed Sale | 1,882 | $18.15 | $34.2K | — | View → |
| Jan 15, 2026 | Jan 20 9:52 PM | Ryan CohlheppDirector, President and COO | Sale | 149 | $18.02 | $2.7K | 213,992(D) | View → |
| Jan 15, 2026 | Jan 15 9:03 PM | Cohlhepp Ryan | Proposed Sale | 149 | $18.02 | $2.7K | — | View → |
| Dec 22, 2025 | Dec 22 9:08 PM | Hyep Ivan | Proposed Sale | 9,200 | $17.87 | $164.4K | — | View → |
| Dec 15, 2025 | Dec 15 9:04 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.70 | $233.8K | — | View → |
| Nov 25, 2025 | Nov 25 9:29 PM | Raben David | Proposed Sale | 5,500 | $18.84 | $103.6K | — | View → |
| Nov 24, 2025 | Nov 24 9:24 PM | Mazumdar Claire | Proposed Sale | 41,163 | $18.86 | $776.4K | — | View → |
| Nov 24, 2025 | Nov 24 9:10 PM | Hyep Ivan | Proposed Sale | 17,795 | $18.55 | $330.1K | — | View → |
| Nov 24, 2025 | Nov 24 9:09 PM | Raben David | Proposed Sale | 5,500 | $18.45 | $101.5K | — | View → |
| Nov 21, 2025 | Nov 21 9:33 PM | Hyep Ivan | Proposed Sale | 605 | $18.15 | $11.0K | — | View → |
| Nov 21, 2025 | Nov 21 9:32 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.05 | $225.6K | — | View → |
| Oct 16, 2025 | Oct 16 8:13 PM | Mazumdar Claire | Proposed Sale | 24,103 | $18.83 | $453.8K | — | View → |
| Oct 15, 2025 | Oct 15 8:20 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.13 | $226.6K | — | View → |
| Oct 15, 2025 | Oct 15 8:18 PM | Mazumdar Claire | Proposed Sale | 13,289 | $18.84 | $250.4K | — | View → |
| Oct 13, 2025 | Oct 14 1:05 PM | Mazumdar Claire | Proposed Sale | 11,445 | $18.92 | $216.5K | — | View → |
| Oct 9, 2025 | Oct 9 8:31 PM | Hyep Ivan | Proposed Sale | 6,415 | $17.89 | $114.8K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | May 12 8:04 PM | William SchelmanChief Medical Officer | Grant/Award | 85,000 | $22.58 | 85,000(D) | View → |
| Apr 27, 2026 | Apr 28 11:49 PM | David RabenChief Medical Officer | Option Exercise | 5,500 | $3.79 | 41,913(D) | View → |
| Apr 21, 2026 | Apr 22 8:53 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 39,744(D) | View → |
| Apr 20, 2026 | Apr 20 11:27 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 15,000 | $3.79 | 161,107(D) | View → |
| Apr 16, 2026 | Apr 20 11:27 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 22,760 | $5.45 | 558,432(D) | View → |
| Apr 15, 2026 | Apr 17 8:55 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 109,334(D) | View → |
| Mar 25, 2026 | Mar 26 11:21 PM | David RabenChief Medical Officer | Option Exercise | 5,500 | $3.79 | 47,413(D) | View → |
| Mar 23, 2026 | Mar 24 11:45 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 48,944(D) | View → |
| Mar 20, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 1,596 | $3.79 | 176,107(D) | View → |
| Mar 19, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 6,905 | $3.79 | 177,703(D) | View → |
| Mar 18, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 6,499 | $3.79 | 184,608(D) | View → |
| Mar 16, 2026 | Mar 17 9:36 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 117,334(D) | View → |
| Mar 9, 2026 | Mar 11 8:47 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 36,766 | $3.79 | 191,107(D) | View → |
| Mar 6, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 3,817 | $3.79 | 227,873(D) | View → |
| Mar 5, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 1,786 | $3.79 | 231,690(D) | View → |
| Mar 4, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 2,631 | $3.79 | 233,476(D) | View → |
| Mar 3, 2026 | Mar 6 12:10 AM | Ryan CohlheppDirector, President and COO | Option Exercise | 12,892 | $3.79 | 125,334(D) | View → |
| Mar 4, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Option Exercise | 2,963 | $3.79 | 79,784(D) | View → |
| Mar 3, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Option Exercise | 13,555 | $3.79 | 82,747(D) | View → |
| Mar 4, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Option Exercise | 16,300 | $3.79 | 52,913(D) | View → |
Page 1 of 2
Next →